Free Trial
NASDAQ:TGAN

Transphorm (TGAN) Stock Price, News & Analysis

$5.10
0.00 (0.00%)
(As of 06/28/2024)
Today's Range
$5.10
$5.10
50-Day Range
$4.75
$5.10
52-Week Range
$1.94
$5.11
Volume
N/A
Average Volume
329,669 shs
Market Capitalization
$316.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.75
TGAN stock logo

About Transphorm Stock (NASDAQ:TGAN)

Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.

TGAN Stock Price History

TGAN Stock News Headlines

Renesas Completes Acquisition of Transphorm
Kiss of death from Joe Biden
As you’ll discover, behind closed doors in D.C. the elites have manufactured a shocking new economic and social crisis that threatens everything. Elon Musk calls it “staggering.”
Kiss of death from Joe Biden
As you’ll discover, behind closed doors in D.C. the elites have manufactured a shocking new economic and social crisis that threatens everything. Elon Musk calls it “staggering.”
See More Headlines
Receive TGAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transphorm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
7/22/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Industry
Semiconductors & related devices
Sub-Industry
N/A
Current Symbol
NASDAQ:TGAN
Fax
N/A
Employees
128
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.75
High Stock Price Target
$8.00
Low Stock Price Target
$3.50
Potential Upside/Downside
+12.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-30,600,000.00
Net Margins
-177.91%
Pretax Margin
-177.91%

Debt

Sales & Book Value

Annual Sales
$18.76 million
Book Value
$0.33 per share

Miscellaneous

Free Float
60,430,000
Market Cap
$316.00 million
Optionable
Not Optionable
Beta
0.57
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Primit A. Parikh Ph.D. (Age 52)
    Co-Founder, President, CEO & Director
    Comp: $390.66k
  • Mr. Cameron McAulay (Age 48)
    Chief Financial Officer
    Comp: $350.66k
  • Dr. Umesh K. Mishra Ph.D. (Age 66)
    Chairman & CTO
    Comp: $180k
  • Mr. Philip Zuk
    Senior Vice President of Business Development & Marketing
  • Mr. Tushar Dhayagude
    Vice President of Worldwide Sales & FAE
  • Mr. Randy Berg
    Human Resources Leader
  • Mr. Sal Barlett
    Senior Vice President of Operations

TGAN Stock Analysis - Frequently Asked Questions

How have TGAN shares performed this year?

Transphorm's stock was trading at $3.65 at the beginning of the year. Since then, TGAN stock has increased by 39.7% and is now trading at $5.10.
View the best growth stocks for 2024 here
.

How do I buy shares of Transphorm?

Shares of TGAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Transphorm own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Transphorm investors own include Adobe (ADBE), American Battery Technology (ABML), Capricor Therapeutics (CAPR), Ciena (CIEN), Editas Medicine (EDIT) and Eros STX Global (EROS).

This page (NASDAQ:TGAN) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners